ReShape Lifesciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RSLS and buy or sell other stocks, ETFs, and their options commission-free!About RSLS
ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device.
CEOPaul F. Hickey
CEOPaul F. Hickey
Employees31
Employees31
HeadquartersSan Clemente, California
HeadquartersSan Clemente, California
Founded2002
Founded2002
Employees31
Employees31
RSLS Key Statistics
Market cap478.45M
Market cap478.45M
Price-Earnings ratio-5.19
Price-Earnings ratio-5.19
Dividend yield—
Dividend yield—
Average volume1.14M
Average volume1.14M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.67
52 Week high$0.67
52 Week low$0.11
52 Week low$0.11
Stock Snapshot
As of today, ReShape Lifesciences(RSLS) shares are valued at $15.68. The company's market cap stands at 478.45M, with a P/E ratio of -5.19.
ReShape Lifesciences(RSLS) stock opened on 2025-12-05 at —. The price climbed to — and dipped to —.
ReShape Lifesciences(RSLS) shares are trading with a volume of 0, against a daily average of 1.14M.
In the last year, ReShape Lifesciences(RSLS) shares hit a 52-week high of $0.67 and a 52-week low of $0.11.
In the last year, ReShape Lifesciences(RSLS) shares hit a 52-week high of $0.67 and a 52-week low of $0.11.
People also own
Based on the portfolios of people who own RSLS. This list is generated using Robinhood data, and it’s not a recommendation.